How vulnerable are natural resources to a pullback?

Especially with China remaining uncertain

clock • 2 min read

The outperformance of the natural resources sector so far this year has caught many investors unaware, causing pain to the relative performance of portfolios, writes Olivia Markham, manager on the BLK Commodities Income investment trust.

The S&P Global Natural Resources index has returned 22%, while the S&P 500 and the MSCI World have only risen 4%. None-the-less, positioning surveys suggest investors remain cautious of the sector, given several years of severe underperformance, and the sector continues to be underowned relative to history. The resources sector's performance year-to-date has been driven by commodity prices bouncing off the multi-year lows we saw at the end of 2015, with Brent oil, gold and iron ore prices up 27%, 23% and 38% for example. Oil jumps 6% as OPEC surprises with production cut Sentiment ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot